Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Study ID: NCT06283927
Start Date: 2023-01-01
End Date: 2028-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

464

Intervention / Treatment

Re-resection

Temozolomide

Lomustine

Re-irradiation

Experimental therapy

Best supportive care

Sponsor

Jasper Gerritsen

Source: clinicaltrials.gov

Share:
Add to list

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Study ID: NCT06067776
Start Date: 2024-01-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

Cetuximab

Osimertinib

Tucatinib

Sponsor

Jonathan Riess

Source: clinicaltrials.gov

Share:
Add to list

A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Study ID: NCT06077760
Start Date: 2023-12-06
End Date: 2035-12-21
Study Type

Interventional

Study Phase

Phase3

No. of Participants

868

Intervention / Treatment

V940

Pembrolizumab

Placebo

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Study ID: NCT05789394
Start Date: 2023-06-16
End Date: 2025-07-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Allogeneic Adipose-derived Mesenchymal Stem Cells

Biospecimen Collection

Craniotomy

Magnetic Resonance Imaging

Ommaya Reservoir Tap

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Glioblastoma Remote Monitoring and Care - Research Protocol

Study ID: NCT06129760
Start Date: 2024-04-30
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Apple Watch

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Neurofibromatosis Type 1 Tumor Early Detection Study

Study ID: NCT06515860
Start Date: 2024-08-07
End Date: 2030-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Liquid biopsy for MPNST development

Sponsor

David Miller

Source: clinicaltrials.gov

Share:
Add to list

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

Study ID: NCT05627960
Start Date: 2022-02-14
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

77

Intervention / Treatment

AG-01 Compound

Sponsor

A&G Pharmaceutical Inc.

Source: clinicaltrials.gov

Share:
Add to list

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

Study ID: NCT05269160
Start Date: 2023-04-24
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

37

Intervention / Treatment

Dermaprazole 1%

Dermaprazole 2%

Sponsor

Michelle S Ludwig

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer

Study ID: NCT04134260
Start Date: 2020-03-05
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

586

Intervention / Treatment

Apalutami

Hormone Therapy

Quality-of-Life Assessment

Administration questionnaire

Radiation Therapy

Sponsor

NRG Oncology

Source: clinicaltrials.gov

Share:
Add to list

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

Study ID: NCT06891560
Start Date: 2025-03-31
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Emportumab Vedotin

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list